OBSTETRIC ASPECTS OF IMPAIRED URINATION IN WOMEN


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the rate of impaired urination during pregnancy, to determine the importance of risk factors, and to elaborate an optimal algorithm for examination and treatment. Subjects and methods. A detailed clinical and laboratory examination was made in 140 women with impaired urination at 20 and 32 weeks’ gestational age and 4 months after labor. Group 1 (a study group) comprised 70 patients who received complex behavioral therapy; Group 2 (a comparison group) included 70patients who dismissed behavioral therapy. A control group consisted of 30 healthy pregnant women matched for main parameters. The authors interviewed using a specially designed questionnaire (518 women), used a clinicoanamnestic method, assessed urination diaries, conducted an objective examination including serum relaxin measurements, uroflowmetry, ultrasonography estimating the urethral sphincter area and the urethrovesical angle (alpha angle), and applied statistical methods. Results. During pregnancy, the rate of impaired urination substantially increases; the risk factors are the preexisting disease before current pregnancy; patient age; a history of pregnancies and vaginal deliveries;previous deliveries of relatively higher birthweight neonates, and body mass index. The optimal method for correction of any type of impaired urination during pregnancy is behavioral therapy that reduces its symptoms during pregnancy and after labor by 3 and 1.9 times, respectively. Conclusion. Evaluation of impaired urination in pregnant women is extraordinarily important and allows high risk-group identification. The detailed clinical and laboratory examination of risk group patients makes it possible to reveal the type and degree of impaired urination and to determine its prognosis. Complex behavioral therapy is an optimal method to treat and prevent impaired urination during pregnancy.

Full Text

Restricted Access

About the authors

L. A KOVALEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia; I.M. Sechenov First Moscow State Medical University

Email: kovalevela@mail.ru
Department of Obstetrics, Gynecology, Perinatology, and Reproductology, Faculty for Postgraduate Training of Physicians Moscow

V. E BALAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Moscow

I. A APOLIKHINA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia; I.M. Sechenov First Moscow State Medical University

Department of Obstetrics, Gynecology, Perinatology, and Reproductology, Faculty for Postgraduate Training of Physicians Moscow

Zh. S AMIROVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Moscow

References

  1. Кузьмин И.В. Патогенез, клиническое течение и лечение гиперактивности мочевого пузыря: Автореф. дис.. канд. мед. наук. — СПб., 2007.
  2. Кулаков В.И., Аполихина И.А. Недержание мочи у женщин: новые возможности в диагностике и лечении // Гинекология. — 2004. — Т. 4, № 3. — С. 103—105.
  3. Bani D., Failli P., Grazia M. Relaxin activates the L-argininenitric oxide pathway in vascular smooth muscle cells in culture // Hypertension. — 1998. — Vol. 31. — P. 1240—1247.
  4. Brown S.J., Gartland D., Donath S. Effects of prolonged second stage, method of birth, timing of caesarean section and other obstetric risk factors on postnatal urinary incontinence: an Australian nulliparous cohort study // Br. J. Obstet. Gynaecol. — 2011. — Vol. 118, № 8. — P. 991—1000.
  5. Brummen H.J., Bruinse H.W., Bom J.G. et al. How do the prevalences of urogenital symptoms change during pregnancy? // Neurourol. Urodyn. — 2006. — Vol. 25. — P. 135—139.
  6. Cardozo L. Pregnancy and childbirth // Textbook of female urology and urogynaecology / Eds L. Cardozo, D. Staskin. — London: Taylor and Francis, 2002. — P. 977-994.
  7. Chapple C.R. Lower urinary tract symptoms in pregnancy // Chapple C.R., MacDiarmid S. A. Urodynamics made easy. — 2 nd ed. — London: Churchill Livingstone, 2000. — P. 149—153.
  8. Cornu J.N., Merlet B., Cussenot O. et al. Genetic susceptibility tu urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways // World J. Urol. — 2011. — Vol. 29, № 2. — P. 239—242.
  9. Ekstrom A., Altman D., Wiklund I. Planned cesarean section versus planned vaginal delivery: comparison of lower urinary tract symptoms // Int. Urogynecol. J. Pelvic Floor Dysfunct. — 2008. — Vol. 19. — P. 459—465.
  10. FitzGerald M., Graziano S. Anatomic and functional changes of the lower urinary tract during pregnancy // Urol. Clin. N. Am. — 2007. — Vol. 34. — P. 7—12.
  11. Granese R., Adile B. Urinary incontinence in pregnancy and in puerperium: 3 months follow-up after delivery // Minerva Ginecol. — 2008. — Vol. 60. — P. 15—21.
  12. Kristiansson P., Svardsudd K., Schoultz B. Serum relaxin, symphyseal pain and back pain during pregnancy // Am. J. Obstet. Gynecol. — 1996. — Vol. 175. — P. 1342—1347.
  13. Meyer J.H. Informed consent, informed refusal and informed choices // Am. J. Obstet. Gynecol. — 2003. — Vol. 189, № 2. — P. 319—326.
  14. Minassian V., Stewart W., Wood G. Urinary incontinence in women: variation in prevalence estimates and risk factors // Obstet. and Gynecol. — 2008. — Vol. 111. — P. 324—331.
  15. Nygaard I., Cruikshanc D. Should all women be offered elective cesarean delivery? // Obstet. and Gynecol. — 2003. — Vol. 102. — P. 217—219.
  16. Prospective Urinary Incocntinence Research — PURE, 2006.
  17. Rotveit G., Hunskaar S. Urinary incontinence and age at the first and last delivery: the Norwegian HUNT/EPINCONT study // Am. J. Obstet. Gynecol. — 2006. — Vol. 195. — P. 433—438.
  18. Sibai B.M., Newton E.R. The urinary tract in pregnancy // Urogynecology and reconstructive pelvic surgery / Eds M. Walters, M. Karram. — 3rd ed. — St Louis: Mosby Elsevier, 2000. — P. 472—490.
  19. Thom D.H., Brown J.S., Schembri M. et al. Parturition events and risk of urinary incontinence in later life // Neurourol. Urodyn. — 2011. — Vol. 30, № 8. — P. 1456—1461.
  20. Viktrup L., Rortveit G., Lose G. Risk of stress urinary incontinence twelve years after the first pregnancy and delivery // Obstet. and gynecol. — 2006. — Vol. 108. — P. 248—254.
  21. Wen Y., Zhao Y., Polan M. Effect of relaxin on TGF-beta 1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence // Reprod. Sci. — 2008. — Vol. 15. — P. 312—320.
  22. Wennberg A.L., Altman D., Lundholm C. et al. Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins // Eur. Urol. — 2011. — Vol. 59, № 6. — P. 1032—1038.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies